Australia's Cynata Therapeutics jumps on Fujifilm deal

Cynata Therapeutics

29/12/2021 01:59

** Shares of Australian biotech firm Cynata Therapeutics
 CYP.AX  rise as much as 4.2% to A$0.500, highest since Dec 8 
    ** Co says it executed a manufacturing services agreement
with human cells manufacturer Fujifilm Cellular Dynamics, a unit
of Japanese conglomerate Fujifilm  4901.T   urn:newsml:reuters.com:*:nASXc1W5rJ
    ** CYP says the deal is for the manufacture and supply of
co's Cymerus therapeutic mesenchymal stem cell products for
clinical trials and commercial applications 
    ** Stock on track for biggest intraday percentage gain since
Dec 22 
    ** Stock down ~29.9% this year, as of last close 

 (Reporting by Tejaswi Marthi in Bengaluru)
 ((tejaswi.marthi@thomsonreuters.com))